PepLabo Download

CagriSema: status with sources, and what PepLabo records.

CagriSema combines an amylin analogue with semaglutide. It has been submitted to the FDA but is not approved. Here is the status and how a personal log works.

Updated

Pep holding a magnifying glass

How to track CagriSema in PepLabo

  1. Add CagriSema as you were given it

    PepLabo records any compound you enter yourself. Pick the form (pen, vial, tablets or other); the library entry shows its current status, with sources.

  2. Enter your own schedule

    Every day, specific weekdays or every X days, one or more times a day, with optional on/off periods. The numbers come from you or your clinician; PepLabo keeps the time.

  3. Log every dose

    Each log saves the date, time and the amount you entered. For vials the calculator converts it to U-100 units; pens and tablets need no unit math.

  4. Rotate injection sites

    Tap where the injection went on a front and back body map. The last site shows on the Today screen, and a weekly heat map shows which areas rested. When you log a dose, it suggests the area you have rested longest among the ones you use, and you can always pick another.

  5. Note how you feel

    A quick check-in records energy, sleep, mood and symptoms such as nausea or an injection-site reaction. You can link it to a dose from the 72 hours before; the app draws no conclusions.

  6. Follow weight, share a report

    Log weight by hand or import it from Apple Health or Health Connect (Pro). A PDF of your dose log (Pro) is ready for your next appointment.

CagriSema at a glance

DetailWhat the sources say
DeveloperNovo Nordisk
What it isCagrilintide (amylin analogue) combined with semaglutide (GLP-1 receptor agonist)
StagePhase 3 (REDEFINE); submitted to the FDA on 18 December 2025
Approved?No, as of the update date
Published evidenceREDEFINE 1, NEJM 2025

From the sources to the app

What the sources sayWhat PepLabo does with it
No approved label exists, so there is no official schedule or storage rule.PepLabo fills in nothing; amounts, schedules and dates come from you or your study team.
CagriSema is a fixed combination of two substances [3].The library lists it as a combination, and it stays a separate product from plain semaglutide in your history.
The phase 3 REDEFINE programme is registered on ClinicalTrials.gov [2].The library entry shows the current status with sources and dates.

What PepLabo does and does not do

PepLabo doesPepLabo does not
Record each dose with the date, time and amount you enter, and the site for injectionsSuggest a dose, a schedule change or a medicine
Remind you 15 minutes before, at the dose time, and 30 minutes after a missed doseTell you what to do after a missed dose; the leaflet and your prescriber do
Put check-ins, weight and doses on one timelineInterpret symptoms or judge progress
Keep your records on your phone, with no account needed to trackUse analytics, advertising or tracking SDKs, or write to Apple Health
Create a PDF of your dose log for your clinician (Pro)Replace your clinician or pharmacist

CagriSema is a name used by Novo Nordisk for an investigational product; PepLabo is not affiliated with Novo Nordisk. PepLabo is a tracking app. It does not sell, supply or recommend any substance, and this page is not medical advice. Investigational medicines are not approved; status details are summarised from the sources below as of the update date.

Questions

Does PepLabo keep CagriSema apart from plain semaglutide?

Yes. Every product you add is its own entry, and the library lists CagriSema as a combination of two substances. A combination and a single substance never merge in your history.

Does PepLabo tell me what CagriSema dose to take?

No. The amount, the timing and the treatment are decided by you and your prescriber; PepLabo writes down what was decided and reminds you when it is due.

Can I log CagriSema if it is not an approved medicine?

Yes. PepLabo records whatever you enter and does not check where a product came from. Its library shows the regulatory status of CagriSema with sources. Whether to use any substance is a decision for you and a qualified clinician, within the law where you live.

Set up your lab tonight.

It takes a few minutes. Pep will be waiting.